Skip to main content
. 2022 May 9;39(7):3131–3145. doi: 10.1007/s12325-022-02148-8

Fig. 1.

Fig. 1

Presence of manifestations* by SELENA-SLEDAI domains over the observation period for the total SLE-MSK population and mean and mean max SLEDAI and PGA scores. *Percentage with SELENA-SLEDAI > 0 at least once for each of the domains over the observation period. CNS central nervous system, MSK musculoskeletal, PGA Physician Global Assessment, SELENA SLEDAI Safety of Estrogens in Lupus National Assessment Systemic Lupus Erythematosus Disease Activity Index, SLE systemic lupus erythematosus